in selected patients , chronic afterload reduction with oral hydralazine may result in increased cardiac reserve , decreased pulmonary congestion or decreased myocardial oxygen demands , thereby improving or abolishing resting or exertional dyspnea or angina .
C0018787
cardiac
C0027061
myocardial